Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
DNA-based traps
Immunotherapy
Lung cancer
Myeloid cells
Journal
Cancer immunology, immunotherapy : CII
ISSN: 1432-0851
Titre abrégé: Cancer Immunol Immunother
Pays: Germany
ID NLM: 8605732
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
09
11
2020
accepted:
13
03
2021
pubmed:
3
4
2021
medline:
24
8
2021
entrez:
2
4
2021
Statut:
ppublish
Résumé
Lung is a specialized tissue where metastases from primary lung tumors takeoff and those originating from extra-pulmonary sites land. One commonality characterizing these processes is the supportive role exerted by myeloid cells, particularly neutrophils, whose recruitment is facilitated in this tissue microenvironment. Indeed, neutrophils have important part in the pathophysiology of this organ and the key mechanisms regulating neutrophil expansion and recruitment during infection can be co-opted by tumor cells to promote growth and metastasis. Although neutrophils dominate the myeloid landscape of lung cancer other populations including macrophages, dendritic cells, mast cells, basophils and eosinophils contribute to the complexity of lung cancer TME. In this review, we discuss the origin and significance of myeloid cells heterogeneity in lung cancer, which translates not only in a different frequency of immune populations but it encompasses state of activation, morphology, localization and mutual interactions. The relevance of such heterogeneity is considered in the context of tumor growth and response to immunotherapy.
Identifiants
pubmed: 33797567
doi: 10.1007/s00262-021-02916-5
pii: 10.1007/s00262-021-02916-5
pmc: PMC8017108
doi:
Substances chimiques
Biomarkers
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2429-2438Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG no. 22204
Organisme : Associazione Italiana per la Ricerca sul Cancro (AIRC)
ID : IG no. 18425
Organisme : Ministero della Salute
ID : Young Research Grant no. GR-2013-02355637
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
J Thorac Oncol. 2018 Jul;13(7):958-967
pubmed: 29684573
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8985-8994
pubmed: 30988194
Eur J Cancer. 2019 Jan;106:144-159
pubmed: 30528799
Sci Transl Med. 2016 Oct 19;8(361):361ra138
pubmed: 27798263
Gut. 2018 Jun;67(6):1112-1123
pubmed: 29196437
J Innate Immun. 2018;10(5-6):414-421
pubmed: 29909412
Immunity. 2017 Dec 19;47(6):1083-1099.e6
pubmed: 29246442
Lung Cancer. 2017 Apr;106:1-7
pubmed: 28285682
Cancer. 2009 Sep 1;115(17):3919-23
pubmed: 19551882
Science. 2018 Sep 28;361(6409):
pubmed: 30262472
J Hematol Oncol. 2020 Jan 31;13(1):10
pubmed: 32005273
JCI Insight. 2019 Jul 25;5:
pubmed: 31343990
Front Immunol. 2019 Jun 20;10:1369
pubmed: 31281314
Nat Commun. 2017 Feb 01;8:14381
pubmed: 28146145
Elife. 2018 Sep 04;7:
pubmed: 30179157
Cell Host Microbe. 2010 Nov 18;8(5):445-54
pubmed: 21075355
Oncoimmunology. 2019 Jan 22;8(4):e1564505
pubmed: 30906658
Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
Cell. 2017 Nov 2;171(4):934-949.e16
pubmed: 29033130
Trends Cancer. 2016 Nov;2(11):633-634
pubmed: 28741500
JAMA Oncol. 2018 Mar 1;4(3):351-357
pubmed: 29327044
Cancer Res. 2016 Mar 1;76(5):999-1008
pubmed: 26833127
Am J Respir Crit Care Med. 2019 Jan 15;199(2):243-246
pubmed: 30339766
Clin Cancer Res. 2019 Feb 1;25(3):989-999
pubmed: 30206165
Nat Immunol. 2019 Jul;20(7):783-792
pubmed: 31213714
Cancer Treat Rev. 2019 May;75:39-51
pubmed: 30954906
Nat Commun. 2020 Oct 16;11(1):5243
pubmed: 33067472
Front Immunol. 2019 Feb 01;9:3101
pubmed: 30774636
Immunobiology. 1982 Apr;161(3-4):274-82
pubmed: 7047374
Nat Commun. 2018 Dec 18;9(1):5361
pubmed: 30560866
Nat Commun. 2018 Nov 30;9(1):5099
pubmed: 30504842
Nat Rev Cancer. 2019 Jan;19(1):9-31
pubmed: 30532012
Cell Rep. 2016 May 31;15(9):2000-11
pubmed: 27210762
Nat Rev Immunol. 2012 Apr 20;12(5):352-66
pubmed: 22517424
J Thorac Oncol. 2019 Sep;14(9):1608-1618
pubmed: 31195179
Lancet. 2017 Jan 21;389(10066):255-265
pubmed: 27979383
PLoS One. 2018 Oct 25;13(10):e0197743
pubmed: 30359383
Cancer Immunol Immunother. 2018 Mar;67(3):459-470
pubmed: 29204702
Lancet Respir Med. 2018 Oct;6(10):771-781
pubmed: 30100403
Cell. 2020 Sep 3;182(5):1232-1251.e22
pubmed: 32822576
J Immunol. 2011 Jul 1;187(1):490-500
pubmed: 21606249
Blood. 2012 Oct 11;120(15):3007-18
pubmed: 22932797
Sci Transl Med. 2011 Mar 9;3(73):73ra19
pubmed: 21389263
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Ann Oncol. 2019 Jul 1;30(7):1104-1113
pubmed: 30977778
Infect Immun. 2009 Feb;77(2):568-75
pubmed: 19015252
Cancer Immunol Immunother. 2020 Feb;69(2):199-213
pubmed: 31982939
Nature. 2014 Nov 6;515(7525):130-3
pubmed: 25337873
Br J Cancer. 2015 Mar 17;112(6):1067-75
pubmed: 25668006
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E478-E487
pubmed: 29295921
J Thorac Oncol. 2016 Aug;11(8):1263-1272
pubmed: 27178984
Int J Cancer. 2017 May 15;140(10):2321-2330
pubmed: 28177522
Trends Immunol. 2018 Nov;39(11):890-899
pubmed: 30253910
Cancer Res. 2005 Oct 15;65(20):9113-6
pubmed: 16230363
Cancer Immunol Res. 2018 Oct;6(10):1260-1273
pubmed: 30012633
Br J Cancer. 2020 Feb;122(3):340-347
pubmed: 31761899
Cell Rep. 2015 Feb 3;10(4):562-73
pubmed: 25620698
N Engl J Med. 2018 May 31;378(22):2093-2104
pubmed: 29658845
Blood. 2017 Mar 9;129(10):1343-1356
pubmed: 28053192
J Thorac Oncol. 2015 Jun;10(6):910-23
pubmed: 25658629
Cancer Cell. 2017 Nov 13;32(5):654-668.e5
pubmed: 29136508
J Leukoc Biol. 2020 May;107(5):809-818
pubmed: 32170882
Cancers (Basel). 2019 Dec 05;11(12):
pubmed: 31817541
Cancer Res. 2005 Apr 15;65(8):3437-46
pubmed: 15833879
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Cancer. 2001 Nov 1;92(9):2399-405
pubmed: 11745296
JAMA Oncol. 2019 Oct 1;5(10):1481-1485
pubmed: 31343662
Sci Transl Med. 2017 May 10;9(389):
pubmed: 28490665
Cancer Discov. 2014 Jan;4(1):110-29
pubmed: 24189145
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
J Clin Invest. 2013 Jul 1;:
pubmed: 23863628
Immunity. 2018 Mar 20;48(3):399-416
pubmed: 29562192
Eur J Cancer. 2019 Feb;108:88-96
pubmed: 30648633
Cell. 2020 Nov 25;183(5):1282-1297.e18
pubmed: 33098771
Nat Rev Clin Oncol. 2019 Oct;16(10):601-620
pubmed: 31160735
Nat Med. 2009 Jun;15(6):623-5
pubmed: 19448636
JAMA Oncol. 2018 Nov 1;4(11):1543-1552
pubmed: 30193240
Front Immunol. 2016 Nov 25;7:518
pubmed: 27933059
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Cell. 2017 Nov 30;171(6):1301-1315.e14
pubmed: 29195074
Cancer Immunol Immunother. 2020 Dec;69(12):2477-2499
pubmed: 32561967
J Thorac Oncol. 2018 Jan;13(1):97-105
pubmed: 29170120
Oncoimmunology. 2014 Aug 03;3(8):e954471
pubmed: 25610747